Your browser doesn't support javascript.
loading
mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.
Beagle, Brandon R; Nguyen, Duc M; Mallya, Sharmila; Tang, Sarah S; Lu, Mengrou; Zeng, Zhihong; Konopleva, Marina; Vo, Thanh-Trang; Fruman, David A.
Affiliation
  • Beagle BR; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Nguyen DM; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Mallya S; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Tang SS; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Lu M; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Zeng Z; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Konopleva M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Vo TT; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fruman DA; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
Oncotarget ; 6(4): 2088-100, 2015 Feb 10.
Article in En | MEDLINE | ID: mdl-25576920

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apoptosis / Enzyme Inhibitors / Histone Deacetylase Inhibitors / TOR Serine-Threonine Kinases Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Oncotarget Year: 2015 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apoptosis / Enzyme Inhibitors / Histone Deacetylase Inhibitors / TOR Serine-Threonine Kinases Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Oncotarget Year: 2015 Type: Article Affiliation country: Canada